Objectives-To assess prospectively the influence of intramuscular gold therapy on Helicobacterpylori serology in patients with rheumatoid arthritis (RA). Methods-Fifty patients with RA were started on intramuscular gold or chloroquine, as the control group and were followed serologically for H pylori infection for 12 months. Results-Twelve patients treated with gold and eight control patients treated with chloroquine, all with serological evidence for H pylori infection, showed no significant decline of IgA and IgG anti-H pyloni antibody levels or serum pepsinogen A and C levels. Total serum IgA and IgG levels declined significantly during gold therapy, while they remained unchanged during chloroquine therapy. Conclusions-Intramuscular gold therapy in patients with RA does not influence the serological parameters of H pylori infection.
IgA and IgG levels declined significantly, while were seropositive to there was no significant decline of anti-Hpyloni 'G antibodies).
IgA and IgG antibody titres and pepsinogen A and C levels. Moreover, the ratio of IgA and IgG antibodies to H pyloni to total serum IgA respectively IgG, and the ratio of pepsinogen A to pepsinogen C did not change during gold therapy. There was no decreasing tendency in any of the serological parameters during chloroquine therapy and there was no significant difference between the treatment groups.
With linear regression analysis none of the patients on gold therapy showed a significant decline of IgG antibody levels against H pylori (fig 1) . One patient with a decline of serum pepsinogen C level died six months after the 12 last value because of a metastatic longcarcinoma (fig 2) . Furthermore there was no rapy ofserum difference in the mean slopes of IgA and IgG ?rological evidence anti-H pylon antibody levels between the gold and chloroquine group (table) . 
